Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 12 studies | 47% ± 11% | |
| basal cell | 11 studies | 27% ± 18% | |
| ciliated cell | 10 studies | 25% ± 5% | |
| epithelial cell | 7 studies | 24% ± 9% | |
| capillary endothelial cell | 6 studies | 22% ± 6% | |
| type II pneumocyte | 6 studies | 25% ± 6% | |
| mesothelial cell | 5 studies | 28% ± 11% | |
| endothelial cell | 5 studies | 26% ± 6% | |
| club cell | 5 studies | 25% ± 8% | |
| podocyte | 4 studies | 36% ± 16% | |
| GABAergic neuron | 3 studies | 38% ± 12% | |
| glutamatergic neuron | 3 studies | 46% ± 12% | |
| smooth muscle cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6420.46 | 1438 / 1445 | 97% | 146.47 | 177 / 183 |
| thymus | 100% | 15689.45 | 653 / 653 | 91% | 257.29 | 550 / 605 |
| lung | 100% | 17338.16 | 578 / 578 | 91% | 136.02 | 1049 / 1155 |
| kidney | 100% | 19287.91 | 89 / 89 | 90% | 166.10 | 808 / 901 |
| ovary | 97% | 3734.56 | 175 / 180 | 90% | 84.22 | 385 / 430 |
| intestine | 99% | 5900.76 | 960 / 966 | 85% | 61.94 | 448 / 527 |
| bladder | 100% | 7396.86 | 21 / 21 | 84% | 136.81 | 424 / 504 |
| stomach | 98% | 5531.38 | 353 / 359 | 83% | 60.44 | 236 / 286 |
| uterus | 100% | 5848.77 | 170 / 170 | 77% | 101.80 | 352 / 459 |
| skin | 98% | 8013.35 | 1775 / 1809 | 78% | 141.11 | 366 / 472 |
| pancreas | 72% | 2236.72 | 236 / 328 | 93% | 166.25 | 165 / 178 |
| adrenal gland | 100% | 7849.07 | 258 / 258 | 62% | 37.87 | 143 / 230 |
| breast | 97% | 5292.63 | 444 / 459 | 58% | 32.16 | 652 / 1118 |
| prostate | 100% | 7839.82 | 245 / 245 | 40% | 14.61 | 200 / 502 |
| blood vessel | 100% | 19554.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 97% | 3923.22 | 234 / 241 | 0% | 0 | 0 / 0 |
| adipose | 96% | 4605.50 | 1153 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 112.48 | 40 / 45 |
| eye | 0% | 0 | 0 / 0 | 85% | 64.93 | 68 / 80 |
| brain | 50% | 1577.90 | 1319 / 2642 | 21% | 14.53 | 146 / 705 |
| heart | 70% | 2170.91 | 603 / 861 | 0% | 0 | 0 / 0 |
| muscle | 31% | 803.84 | 251 / 803 | 0% | 0 | 0 / 0 |
| liver | 2% | 63.27 | 4 / 226 | 11% | 12.20 | 46 / 406 |
| peripheral blood | 0% | 6.84 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
| GO_0097205 | Biological process | renal filtration |
| GO_0017015 | Biological process | regulation of transforming growth factor beta receptor signaling pathway |
| GO_0030324 | Biological process | lung development |
| GO_0035640 | Biological process | exploration behavior |
| GO_0034698 | Biological process | response to gonadotropin |
| GO_0033627 | Biological process | cell adhesion mediated by integrin |
| GO_0010976 | Biological process | positive regulation of neuron projection development |
| GO_0007507 | Biological process | heart development |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
| GO_0030510 | Biological process | regulation of BMP signaling pathway |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0099560 | Biological process | synaptic membrane adhesion |
| GO_0001764 | Biological process | neuron migration |
| GO_0048333 | Biological process | mesodermal cell differentiation |
| GO_0031345 | Biological process | negative regulation of cell projection organization |
| GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
| GO_0007229 | Biological process | integrin-mediated signaling pathway |
| GO_0050900 | Biological process | leukocyte migration |
| GO_0072006 | Biological process | nephron development |
| GO_0097062 | Biological process | dendritic spine maintenance |
| GO_0007613 | Biological process | memory |
| GO_0007266 | Biological process | Rho protein signal transduction |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0030111 | Biological process | regulation of Wnt signaling pathway |
| GO_0043588 | Biological process | skin development |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0010634 | Biological process | positive regulation of epithelial cell migration |
| GO_0060135 | Biological process | maternal process involved in female pregnancy |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031594 | Cellular component | neuromuscular junction |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0097060 | Cellular component | synaptic membrane |
| GO_0048787 | Cellular component | presynaptic active zone membrane |
| GO_0008305 | Cellular component | integrin complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0031527 | Cellular component | filopodium membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0071944 | Cellular component | cell periphery |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_1990812 | Cellular component | growth cone filopodium |
| GO_0060076 | Cellular component | excitatory synapse |
| GO_0034667 | Cellular component | integrin alpha3-beta1 complex |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0001968 | Molecular function | fibronectin binding |
| GO_0005178 | Molecular function | integrin binding |
| GO_0002020 | Molecular function | protease binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0043236 | Molecular function | laminin binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ITGA3 |
| Protein name | Integrin subunit alpha 3 Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain] |
| Synonyms | MSK18 |
| Description | FUNCTION: Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. .; FUNCTION: (Microbial infection) Integrin ITGA3:ITGB1 may act as a receptor for R.delemar CotH7 in alveolar epithelial cells, which may be an early step in pulmonary mucormycosis disease progression. . |
| Accessions | D6R9X8 K7EMU3 ENST00000504417.1 ENST00000007722.11 [P26006-1] ENST00000320031.13 [P26006-2] H0YA49 P26006 ENST00000506401.6 ENST00000506827.1 ENST00000510809.1 ENST00000512553.5 K7EQJ2 H0YA32 |